Market Overview

VirtualScopics, Inc. Issues Annual Shareholder Meeting Proposal

Related VSCP
VirtualScopics Licences IXICO's Proprietary TrialTracker™ Digital Platform
UPDATE: Dawson James Securities Raises PT on VirtualScopics Following 2013 Annual Meeting

VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, today announced that shareholders have voted for and ratified all four proposals contained in the company's 2014 proxy statement. The outcome of yesterday's vote at the Annual Meeting of Shareholders is as follows:

  • Re-elected to the Board of Directors to serve until the 2015 Annual Meeting are Robert G. Klimasewski, Eric T. Converse, Bruce L. Lev, Charles E. Phelps and Terence A. Walts. David Rubin, who serves as the director designee of the holders of the company's Series C-1 preferred stock, has also been re-elected.
  • Marcum LLP was named the company's independent registered public accounting firm for the fiscal year ending December 31, 2014.
  • Approval of an amendment to the company's Certificate of Incorporation to decrease the authorized common stock and authorized undesignated preferred stock.
  • Approval of compensation for certain executive officers.

Five members of VirtualScopics' senior management team made presentations reviewing the company's business and future outlook. The Annual Meeting of Shareholders was webcast live and a replay of the meeting and accompanying slide presentations can be found on the company's website, www.virtualscopics.com, under "investors" and "webcasts" or at http://www.investorcalendar.com/IC?CEPage.asp?ID=172786.

Posted-In: News Management

 

Related Articles (VSCP)

Around the Web, We're Loving...

Get Benzinga's Newsletters